MESO

Mesoblast Limited - American Depositary Shares (MESO)

About Mesoblast Limited - American Depositary Shares (MESO)

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Details

Daily high

$10.98

Daily low

$10.60

Price at open

$10.74

52 Week High

$22.00

52 Week Low

$5.78

Market cap

1.4B

Dividend yield

0.00%

Volume

106,288

Avg. volume

217,976

P/E ratio

-11.71

Mesoblast Limited - American Depositary Shares News